• Explore /
  • Poster
  • / Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC).

Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC).

Abstract Poster

Authors

null

Robin Kate Kelley

University of California San Francisco, San Francisco, CA

Robin Kate Kelley , Emily Mitchell , Spencer Behr , Jimmy Hwang , Bridget Keenan , John Dozier Gordan , Andrew H. Ko , Pelin Cinar , Chloe Evelyn Atreya , Katherine Van Loon , Thomas Weber , Zoe Ngo , Zoe E. Quandt , Chienying Liu , Alan P. Venook , Lawrence Fong , Alexander Cheung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02703714

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 386)

DOI

10.1200/JCO.2018.36.4_suppl.386

Abstract #

386

Poster Bd #

H23

Abstract Disclosures

Similar Posters

First Author: Robin Kate Kelley

First Author: Robin Kate Kelley

First Author: Nicholas Coupe

First Author: Sandra P. D'Angelo